Skip to main content
Veterinary Medicines

ALBIOTIC

Authorised
  • Lincomycin hydrochloride
  • NEOMYCIN SULFATE

Product identification

Medicine name:
ALBIOTIC
Active substance:
  • Lincomycin hydrochloride
  • NEOMYCIN SULFATE
Target species:
  • Cattle (dairy cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    330.00
    milligram(s)
    /
    10.00
    millilitre(s)
  • NEOMYCIN SULFATE
    100.00
    milligram(s)
    /
    10.00
    millilitre(s)
Pharmaceutical form:
  • Intramammary solution
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dairy cow)
      • Meat and offal
        3
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RF03
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet J.S.C.
Responsible authority:
  • The Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 1281 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."